Sarvam: When US slams the door, India begins to find its own openingSarvam AI’s rise to a $1.5 bn valuation after raising $234 mn marks a major milestone for India’s push toward AI sovereignty. The funding c...
16 Jun, 2026, 07.04 PM IST
UPI underdogs seek fair play; WhatsApp tightens scam defencesSmaller UPI players will meet NPCI to curb the growth of industry leaders PhonePe, Google Pay and Paytm. This and more in today’s ETtech To...
29 Apr, 2026, 07.43 PM IST
Govt allows Remdesivir exports under licence“The export of injection Remdesivir and its API… have been put under Restricted category with immediate effect. The export of Remdesivir In...
14 Jun, 2021, 10.12 PM IST
India may allow Remdesivir exporters to sell drug in domestic marketThe measure is expected to boost availability of the drug that’s being used for Covid treatment. Supplies of the drug have been running low...
29 Apr, 2021, 06.39 AM IST
Remdesivir exporters in a spot after shipments banAny duty-free import allowed under advance licence has to be matched with exports, but exporters manufacturing remdesivir have been barred ...
26 Apr, 2021, 10.06 AM IST
Government lifts export ban on anti-malarial drug hydroxychloroquine"The export policy of Hydroxychloroquine API (active pharmaceutical ingredients) and its formulations from prohibited to free with immediat...
18 Jun, 2020, 08.58 PM IST
View: It’s time for India to play hardball with Donald TrumpIndia doesn't need to be as disrespectful as Trump is. But it must seize the chance for a diplomatic payback.
12 Apr, 2020, 03.30 PM IST
A moment when India can save lives, we can’t let it go: PM Modi on lifting HCQ banPrime Minister Narendra Modi insisted that India help out other countries that need hydroxycholoroquine rather than opting for a blanket ex...
12 Apr, 2020, 10.18 AM IST
Pakistan bans export of anti-malaria drugs amid spike in coronavirus casesThe ban, which has been imposed with immediate effect, will remain till the National Coordination Comm-ittee (NCC) on COVID-19 deems necess...
11 Apr, 2020, 03.39 PM IST
Pharma cos don't see supply shortage, oppose exports banGlaxosmithkline India (GSK), one of the largest manufacturers of branded paracetamol in India, said it does not anticipate any supply short...
19 Feb, 2020, 07.54 AM IST
26% dip in drug ingredient import from ChinaIn 2017, India imported 354 Active Pharmaceutical Ingredients (APIs) from China, a 26% dip compared to 447 in 2015.
22 Jan, 2018, 11.23 AM IST
Drug crisis in store if Sino-Indian ties worsenIndia imports around 85% of Active Pharmaceutical Ingredients (API) used in medicine formulations from China.
04 Oct, 2016, 11.59 AM IST
USFDA slaps ban on API supplied by India’s LaxachemThe USFDA has banned products of Laxachem Organics, a maker of active pharmaceutical ingredients, from US markets as part of the effort to ...
20 Sep, 2016, 08.31 AM IST
Ranbaxy Laboratories' TL Easwar of API quits post ‘introspection’A few weeks after the meeting, its head of API manufacturing, TL Easwar, left the company, two people with direct knowledge of the matter t...
09 Apr, 2014, 06.31 AM IST
Ranbaxy slips as USFDA refuses request to allow exports from banned unitsThe USFDA prohibited Ranbaxy Labs from manufacturing and distributing APIs from its Toansa plant for FDA-regulated drug products.
12 Feb, 2014, 10.22 AM IST
Brokerages cautious on Ranbaxy post Q4 show; stock down over 20% in 2014Analysts have maintained their cautious stance on Ranbaxy Laboratories even though the drugmaker reported a drastic drop in net loss.
06 Feb, 2014, 04.11 PM IST
- Ranbaxy ban to help Chinese companies
US Food and Drug Administration’s ban on seven API products of Ranbaxy may turn out to be a boon for the company’s Chinese peers, according...
23 Sep, 2008, 11.47 PM IST